Health
Sabari Stresses the Importance of Molecular Testing in Lung Cancer – OncLive
Joshua K. Sabari, MD, discussed the management of patients with early-stage and metastatic lung cancer, the roles of molecular testing, surgery, staging, and ongoing…
Concurrent tissue- and plasma-based testing is needed in all patients to understand tumor heterogeneity, identify potential de novo resistance mutations, and ensure that existing mutations are not missed by potentially false negative results of liquid biopsy, according to Joshua K. Sabari, MD.
Despite all of our advances in lung cancer, unfortunately this disease is often incurable, explained Sabari. Even in the era of immunotherapy, it is critically important to not forget molecular testing. PD-L1…
-
General21 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General19 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News22 hours agoATO investigator found to have lied in fraud case
-
Noosa News19 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW